| RadNet Reports First Quarter Financial Results and Reaffirms 2010 Full-Year Guidance (GlobeNewswire) LOS ANGELES -- RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 190 fully-owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2010. us.rd.yahoo.com |
Curves Loses Stamina, Closes Clubs Curves, whose 30-minute workout for women once made it among the world's fastest-growing franchises, seems to be running out of steam. online.wsj.com |
Eli Lilly Loses Appeal in Gemzar Patent Case A federal appeals court ruled Wednesday that an Eli Lilly Co. patent for anti-cancer drug Gemzar is invalid, a decision that may clear the way for generic competition to the drug late this year. online.wsj.com |
The Catalysts That Will Propel Cyclacel Pharmaceuticals Higher Jeremy Richards submits:Cyclacel Pharmaceuticals (CYCC) is trading at unrealistically low levels and hence is an amazing buy. Several recent developments and upcoming near-term catalysts are expected to propel the stock at or above $4 levels which were seen earlier this year: PipelineComplete Story » seekingalpha.com |
Bilingualism May Build Stronger Brains A lifetime of speaking two or more languages appears to pay off in old age, with recent research showing the symptoms of dementia can be delayed by an average of four years in bilingual people. online.wsj.com |